Apogee Therapeutics Inc
APGELatest QuantConomy context for APGE: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Apogee Therapeutics Inc
QuantConomy has a structured record for APGE. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- APGE
- Name
- Apogee Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- alphavantage fmp alpaca sec nasdaq
Recent signals for APGE
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| proposed sale standard proposed sale | slightly bearish | 27 | Jul 1, 09:10 PM | CARL DAMBKOWSKI filed Form 144 to sell APGE shares ($2.19M) - 16,500 shares - expected around 7/1/2026 - [very weak slightly bearish signal - supply pressure] |
| insider trade large sale | very bearish | 32 | Jun 25, 12:03 AM | Dambkowski Carl sold APGE shares ($3.50M) - 26,400 shares - [very weak very bearish signal] |
| insider trade large sale | very bearish | 33 | Jun 25, 12:01 AM | HENDERSON MICHAEL THOMAS sold APGE shares ($10.60M) - 80,000 shares - [very weak very bearish signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PROPOSED_SALE signals are experimental: historical Form 144 coverage is still being backfilled, so results may be sparse or empty.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| APGE | NASDAQ | alphavantage | Apogee Therapeutics Inc |
| APGE | NASDAQ | fmp | Apogee Therapeutics, Inc. |
| APGE | NASDAQ | alpaca | Apogee Therapeutics, Inc. Common Stock |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | sale | 80,000 | $132.54 | $10,603,200 | 4 on EDGAR |
| Jun 22, 2026 | Dambkowski Carl | Chief Medical Officer | sale | 26,400 | $132.60 | $3,500,640 | 4 on EDGAR |
| Jun 10, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | sale | 6,770 | $82.21 | $556,562 | 4 on EDGAR |
| Jun 9, 2026 | Fairmount Funds Management LLC | Insider | grant | 7,657 | — | — | 4 on EDGAR |
| Jun 9, 2026 | Fox Jennifer A. | Insider | grant | 7,657 | — | — | 4 on EDGAR |
| Jun 9, 2026 | McKenna Mark C. | Insider | grant | 7,657 | — | — | 4 on EDGAR |
| Jun 9, 2026 | JONES WILLIAM A JR | Insider | grant | 7,657 | — | — | 4 on EDGAR |
| Jun 9, 2026 | Shah Nimish P | Insider | grant | 7,657 | — | — | 4 on EDGAR |
| Jun 9, 2026 | Bollinger Lisa | Insider | grant | 7,657 | — | — | 4 on EDGAR |
| Jun 3, 2026 | Dambkowski Carl | Chief Medical Officer | exercise | 4,125 | $22.86 | $94,298 | 4 on EDGAR |
| May 13, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | sale | 18,659 | $82.05 | $1,530,971 | 4 on EDGAR |
| May 6, 2026 | Dambkowski Carl | Chief Medical Officer | exercise | 4,125 | $22.86 | $94,298 | 4 on EDGAR |
| May 1, 2026 | Henderson Jane | Chief Financial Officer | sale | 811 | $81.02 | $65,707 | 4 on EDGAR |
| Apr 16, 2026 | Henderson Jane | Chief Financial Officer | sale | 2,000 | $90.00 | $180,000 | 4 on EDGAR |
| Apr 16, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | exercise | 3,000 | $22.86 | $68,580 | 4 on EDGAR |
| Apr 8, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | sale | 17,800 | $82.48 | $1,468,144 | 4 on EDGAR |
| Apr 1, 2026 | Henderson Jane | Chief Financial Officer | sale | 900 | $84.46 | $76,014 | 4 on EDGAR |
| Apr 1, 2026 | Dambkowski Carl | Chief Medical Officer | exercise | 4,125 | $22.86 | $94,298 | 4 on EDGAR |
| Mar 25, 2026 | Henderson Jane | Chief Financial Officer | sale | 2,000 | $85.00 | $170,000 | 4 on EDGAR |
| Mar 11, 2026 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | sale | 8,363 | $74.29 | $621,287 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query APGE context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access